Evidence map›Paper›PMID 39035049›Full record

ArticleOncology letters2024

Machine learning‑based radiomics models accurately predict Crohn's disease‑related anorectal cancer.

Yuki Horio, Jota Ikeda, Kentaro Matsumoto, Shinichiro Okada, Kentaro Nagano, Kurando Kusunoki, Ryuichi Kuwahara, Kei Kimura, Kozo Kataoka, Naohito Beppu and 5 more

Abstract read
In one paragraph

Article in Oncology letters, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Yuki HorioDepartment of Gastroenterological Surgery, Hyogo Medical University, Nishinomiya, Hyogo 663-8501, Japan.
Jota IkedaDepartment of Radiology, Hyogo Medical University, Nishinomiya, Hyogo 663-8501, Japan.
Kentaro MatsumotoDepartment of Science and Engineering, Kwansei Gakuin University, Sanda, Hyogo 669-1330, Japan.
Shinichiro OkadaDepartment of Science and Engineering, Kwansei Gakuin University, Sanda, Hyogo 669-1330, Japan.
Kentaro NaganoDepartment of Gastroenterological Surgery, Hyogo Medical University, Nishinomiya, Hyogo 663-8501, Japan.
Kurando KusunokiDepartment of Gastroenterological Surgery, Hyogo Medical University, Nishinomiya, Hyogo 663-8501, Japan.
Ryuichi KuwaharaDepartment of Gastroenterological Surgery, Hyogo Medical University, Nishinomiya, Hyogo 663-8501, Japan.
Kei KimuraDepartment of Gastroenterological Surgery, Hyogo Medical University, Nishinomiya, Hyogo 663-8501, Japan.
Kozo KataokaDepartment of Gastroenterological Surgery, Hyogo Medical University, Nishinomiya, Hyogo 663-8501, Japan.
Naohito BeppuDepartment of Gastroenterological Surgery, Hyogo Medical University, Nishinomiya, Hyogo 663-8501, Japan.
Motoi UchinoDepartment of Gastroenterological Surgery, Hyogo Medical University, Nishinomiya, Hyogo 663-8501, Japan.
Masataka IkedaDepartment of Gastroenterological Surgery, Hyogo Medical University, Nishinomiya, Hyogo 663-8501, Japan.
Takeshi OkadomeDepartment of Science and Engineering, Kwansei Gakuin University, Sanda, Hyogo 669-1330, Japan.
Koichiro YamakadoDepartment of Radiology, Hyogo Medical University, Nishinomiya, Hyogo 663-8501, Japan.
Hiroki IkeuchiDepartment of Gastroenterological Surgery, Hyogo Medical University, Nishinomiya, Hyogo 663-8501, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The radiological diagnosis of Crohn's disease (CD)-related anorectal cancer is difficult; it is often found in advanced stages and has a poor prognosis because of the difficulty of curative surgery. However, there are no studies on predicting the diagnosis of CD-related cancer. The present study aimed to develop a predictive model to diagnose CD cancerous lesions more accurately in a way that can be interpreted by clinicians. Patients with CD who developed anorectal CD lesions at Hyogo Medical University (Nishinomiya, Japan) between March 2009 and June 2022 were included in the present study. T2-weighted and T1-weighted magnetic resonance (MR) images were utilized for our analysis. Images of anorectal lesions were segmented using open-source 3D Slicer software, and radiomic features were extracted using PyRadiomics. Six machine learning models were investigated and compared: i) Support vector machine; ii) naive Bayes; iii) random forest; iv) light gradient boosting machine; v) extremely randomized trees; vi) and regularized greedy forest (RGF). SHapley Additive exPlanations (SHAP) values were calculated to assess the extent to which each radiomic feature contributed to the model's predictions compared to baseline, represented as the average of the model's predictions for all test data. The T2-weighted images of 28 patients with anorectal cancer and 40 non-cancer patients were analyzed and the contrast-enhanced T1-weighted images of 22 cancer and 40 non-cancer patients. The model with the highest area under the curve (AUC) was the RGF-based model constructed using T2-weighted image features, achieving an AUC of 0.944 (accuracy, 0.862; recall, 0.830). The SHAP-based model explanation suggested a strong association between the diagnosis of CD-related anorectal cancer and features such as complex lesion texture; greater pixel separation within the same coronal cross-section; larger, randomly distributed clumps of pixels with the same signal intensity; and a more spherical lesion shape on T2-weighted images. The MRI radiomics-based RGF model demonstrated outstanding performance in predicting CD-related anorectal cancer. These results may affect the diagnosis and surveillance strategies of CD-related colorectal cancer.

Indexed as

anorectal cancerCrohn's diseasemachine learningMRIradiomics

Identifiers

PMID39035049
PMCPMC11258598

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.